Skip to main content
Log in

Metabolic, inflammatory, endothelial and haemostatic markers in a group of Italian obese children and adolescents

  • Original Paper
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Childhood obesity and its related comorbidities are increasingly recognised in children, predisposing them to early cardiovascular disease and metabolic syndrome. The objective of the study was to investigate markers of metabolism, inflammation and haemostasis in a group of Italian obese children and adolescents. Fifty-nine obese and 40 non-obese subjects were recruited. Fasting glucose and insulin, total cholesterol, HDL and LDL cholesterol, triglycerides, high-sensitivity C-reactive protein (hsCRP), tumour necrosis factor alpha (TNF-α), and adiponectin were measured. Hypercoagulability was assessed by measuring the circulating levels of thrombin-antithrombin complex (TAT), D-dimer, fibrinogen, plasminogen activator inhibitor 1 (PAI-1) and von Willebrand Factor (vWF). A significant degree of insulin resistance was present in obese subjects compared with controls (p < 0.0001). The obese showed higher levels of total cholesterol, LDL cholesterol and triglycerides, and lower levels of HDL cholesterol than controls (p < 0.0001). Circulating levels of hsCRP and TNF-α were significantly higher in obese than in controls while serum adiponectin levels were significantly lower in obese than non-obese subjects (p < 0.001; p = 0.031; p < 0.0001, respectively). vWF, TAT, D-dimer, fibrinogen and PAI-1 levels were significant higher in obese subjects compared with control group (p = 0.02; p < 0.0001; p = 0.0037; p < 0.0001; p = 0.017, respectively). In conclusion, our results suggest that childhood obesity per se is associated with a proinflammatory and prothrombotic state.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Am C, Caprio S (2008) Obesity in children and adolescents. J Clin Endocrinol Metab 93:S31–S36

    Article  Google Scholar 

  2. Atabek ME (2008) Relationship between endothelial dysfunction, carotid artery intima media thickness and circulating markers of vascular inflammation in obese hypertensive children and adolescents. J Pediatr Endocrinol Metab 21:603–604

    PubMed  Google Scholar 

  3. Caballero AE, Bousquet-Santos K, Robles-Osorio L et al (2008) Overweight Latino children and adolescents have marked endothelial dysfunction and subclinical vascular inflammation in association with excess body fat and insulin resistance. Diab Care 31:576–582

    Article  CAS  Google Scholar 

  4. Cacciari E, Milani S, Balsamo A et al (2006) Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). J Endocrinol Investig 29:581–593

    CAS  Google Scholar 

  5. Cole TJ, Bellizzi MC, Flegal KM et al (2000) Establishing a standard definition for child overweight and obesity worldwide: International survey. Brit Med J 7244:1240–1243

    Article  Google Scholar 

  6. Cook JM, Semple RK (2010) Hypoadiponectinemia—cause or consequence of human “insulin resistance”? J Clin Endocrinol Metab 95:1544–1554

    Article  PubMed  CAS  Google Scholar 

  7. Daniels SR (2006) The consequences of childhood overweight and obesity. Future Child 16:47–67

    Article  PubMed  Google Scholar 

  8. Ferguson MA, Gutin B, Owens S et al (1999) Effect of physical training and its cessation on the hemostatic system of obese children. Am J Clin Nutr 69:1130–1134

    PubMed  CAS  Google Scholar 

  9. Gallistl S, Sudi KM, Borkenstein M et al (2000) Correlation between cholesterol, soluble P-selectin, and D-dimer in obese children and adolescents. Blood Coagul Fibrinolysis 11:755–760

    Article  PubMed  CAS  Google Scholar 

  10. Gilardini L, McTernan PG, Girola A et al (2006) Adiponectin is a candidate marker of metabolic sindrome in obese children and adolescents. Atherosclerosis 189:401–407

    Article  PubMed  CAS  Google Scholar 

  11. Hotamisligil GS (2003) Inflammatory pathways and insulin action. Int J Obes 27:S53–S55

    Article  CAS  Google Scholar 

  12. Iñiguez G, Torrealba IM, Avila A et al (2008) Adiponectin serum levels and their relationships to androgen concentrations and ovarian volume during puberty in girls with type 1 diabetes mellitus. Horm Res 70:112–117

    Article  PubMed  Google Scholar 

  13. Kato H, Kahiwagi H, Shiraga M et al (2006) Adiponectin acts as an endogenous antithrombotic factor. Arterioscler Thromb Vasc Biol 26:224–230

    Article  PubMed  CAS  Google Scholar 

  14. Klein S, Burke LE, Bray GA, American Heart Association Council on Nutrition, Physical Activity, and Metabolism et al (2004) Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation 110:2952–2967

    Article  PubMed  Google Scholar 

  15. Martos R, Valle M, Morales RM et al (2009) Changes in body mass index are associated with changes in inflammatory and endothelial dysfunction biomarkers in obese prepubertal children after 9 months of body mass index SD score loss. Metabolism 58:1153–1160

    Article  PubMed  CAS  Google Scholar 

  16. Masuccio FG, Lattanzio FM, Matera S et al (2009) Insulin sensitivity in prepubertal Caucasian normal weight children. J Clin Endocrinol Metab 22:695–702

    CAS  Google Scholar 

  17. Mauras N, Delgiorno C, Kollman C et al (2010) Obesity without established comorbidities of the metabolic syndrome is associated with a proinflammatory and prothrombotic state, even before the onset of puberty in children. J Clin Endocrinol Metab 95:1060–1068

    Article  PubMed  CAS  Google Scholar 

  18. Meigs JB, O’donnell CJ, Tofler GH et al (2006) Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study. Diabetes 55:530–537

    Article  PubMed  CAS  Google Scholar 

  19. Ritchie SA, Connell JM (2007) The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis 17:319–26

    Article  PubMed  CAS  Google Scholar 

  20. Romano M, Guagnano MT, Pacini G (2003) Association of inflammation markers with impaired insulin sensitivity and coagulative activation in obese healthy women. J Clin Endocrinol Metab 88:5321–5326

    Article  PubMed  CAS  Google Scholar 

  21. Tan KC, Xu A, Chow WS et al (2004) Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation. J Clin Endocrinol Metab 89:765–769

    Article  PubMed  CAS  Google Scholar 

  22. Tanner JM, Whitehouse RH (1976) Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 51:170–179

    Article  PubMed  CAS  Google Scholar 

  23. Tchernova J, Whincup P, Lowe GD et al (2009) Plasma leptin: associations with metabolic, inflammatory and hemostatic risk factors for cardiovascular disease. Atherosclerosis 191:418–426

    Google Scholar 

  24. Valle Jiménez M, Estepa RM, Camacho RM et al (2007) Endothelial dysfunction is related to insulin resistance and inflammatory biomarker levels in obese prepubertal children. Eur J Endocrinol 156:497–502

    Article  PubMed  Google Scholar 

  25. Valle M, Martos R, Gascon F et al (2005) Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome. Diab Metab 31:55–62

    Article  CAS  Google Scholar 

  26. Weiss R, Dziura J, Burgert TS et al (2004) Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350:2362–2374

    Article  PubMed  CAS  Google Scholar 

  27. Williams CL, Hayman LL, Daniels SR et al (2002) Cardiovascular health in childhood: a statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 106:143–160

    Article  PubMed  Google Scholar 

  28. World Health Organization Department of Non communicable Disease Surveillance (1999). Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation, Geneva, World Health Organization

  29. Wozniak SE, Gee LL, Wachtel MS et al (2009) Adipose tissue: the new endocrine organ? A review article. Dig Dis Sci 54:1847–1856

    Article  PubMed  Google Scholar 

  30. Yamamoto K, Takeshita K, Tetsuhito K et al (2005) Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in elderly. Cardiovasc Res 66:276–285

    Article  PubMed  CAS  Google Scholar 

  31. Yasar S, Nurgun K, Ayfer A et al (2008) Prevalence and risk factors of metabolic syndrome in obese children and adolescents: the role of the severity of obesity. Eur J Pediatr 167:1183–1189

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maria Felicia Faienza.

Additional information

The authors do not have any financial relationship with the organization that sponsored the research.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Giordano, P., Del Vecchio, G.C., Cecinati, V. et al. Metabolic, inflammatory, endothelial and haemostatic markers in a group of Italian obese children and adolescents. Eur J Pediatr 170, 845–850 (2011). https://doi.org/10.1007/s00431-010-1356-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-010-1356-7

Keywords

Navigation